CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-09 | SCHAFER GREGORY W Director | Grant or award · Stock Option (right to buy) | +83,661 | 83,661 | ||
| 2013-11-20 | Kazam Joshua A Director | Other acquisition | +1,875 | 30,988 | ||
| 2013-11-20 | Kazam Joshua A Director | Other disposition · Warrant (right to buy) | −1,875 | 0 | ||
| 2013-11-13 | Kazam Joshua A Director | Other acquisition | +50 | 29,113 | ||
| 2013-11-13 | Kazam Joshua A Director | Other disposition · Warrant (right to buy) | −988 | 0 | ||
| 2013-11-13 | Kazam Joshua A Director | Other disposition · Warrant (right to buy) | −988 | 0 | ||
| 2013-11-13 | Kazam Joshua A Director | Other disposition · Warrant (right to buy) | −1,976 | 0 | ||
| 2013-11-13 | Kazam Joshua A Director | Other disposition · Warrant (right to buy) | −633 | 0 | ||
| 2013-10-23 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −2,178 | 0 | ||
| 2012-03-30 | Evans Daron Chief Financial Officer | Purchase | +12,500 | 25,652 | ||
| 2012-03-30 | Evans Daron Chief Financial Officer | Purchase · Warrant (Right to Buy) | +9,375 | 9,375 | ||
| 2012-03-30 | Lieu Hsiao Executive VP, Clinical Dev. | Purchase | +12,500 | 12,600 | ||
| 2012-03-30 | Lieu Hsiao Executive VP, Clinical Dev. | Purchase · Warrant (Right to Buy) | +9,375 | 9,375 | ||
| 2012-03-30 | Kazam Joshua A President & CEO | Purchase | +125,000 | 1,453,228 | ||
| 2012-03-30 | Kazam Joshua A President & CEO | Purchase · Warrant (Right to Buy) | +93,750 | 93,750 | ||
| 2012-03-30 | BREWER RICHARD B Executive Chairman | Purchase | +125,000 | 125,000 | ||
| 2012-03-30 | BREWER RICHARD B Executive Chairman | Purchase · Warrant (Right to Buy) | +93,750 | 93,750 | ||
| 2011-07-18 | KASH PETER M Director | Other acquisition · Warrant (Right to Buy) | +19,500 | 19,500 | ||
| 2011-05-26 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2011-05-10 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 |
Page 25 of 31 · 605 trades